Luomaranta Tuomas, Raappana Antti, Saarela Ville, Liinamaa M Johanna
Department of Ophthalmology, Oulu University Hospital, Oulu, Finland; Department of Otorhinolaryngology, Oulu University Hospital, Oulu, Finland; MRC Oulu, University of Oulu, Oulu, Finland; PEDEGO Research Unit, University of Oulu, Oulu, Finland.
Department of Otorhinolaryngology, Oulu University Hospital, Oulu, Finland; PEDEGO Research Unit, University of Oulu, Oulu, Finland.
World Neurosurg. 2017 Sep;105:422-431. doi: 10.1016/j.wneu.2017.05.144. Epub 2017 Jun 2.
To evaluate visual acuity (VA) and visual fields (VF) quantitatively before and after endoscopic transsphenoidal surgery (ETS), with special attention to prognostic factors such as the pituitary adenoma (PA) suprasellar extension (SSE), volume and the patients' age.
Medical records of 47 patients with PA undergoing ETS were evaluated. VA, VF, preoperative visual impairment score (VISpre) and postoperative visual impairment score (VISpost) were determined. The PA SSE, volume, chiasmal contact, and their correlation with visual function were assessed preoperatively and postoperatively.
The final cohort included 47 patients. VA improved in 54 of 76 eyes (71.0%) after ETS, and 69 of 76 eyes (90.7%) gained normal VA. Postoperative VF recovery occurred in 32 of 37 eyes (86.5%). The mean change in VIS was 12.0 (95% confidence interval [CI], 7.7-16.3) and improved in all patients with tumor-related visual impairment (n = 25). However, visual outcome was poorer when VISpre was greater than 40. When VISpre was 21-40, age linearly correlated with VIS improvement (P = 0.03); younger patients had satisfactory and older poorer visual outcome. The mean SSE in patients with VF defects (n = 20) was 16.6 mm (95% CI, 13.3-19.9). Mean SSE in patients with no VF defects (n = 23) was 6.6 mm (95% CI, 4.9-8.3; P < 0.001), and the cutoff value for visual perturbations was 9.5 mm for SSE and 8.6 mL for PA volume (P < 0.001 for both).
The visual outcome after ETS for PAs was excellent, and serious complications were rare. Severe preoperative visual impairment resulted in poorer postoperative visual outcomes. The SSE of the PA was the most important predictor of visual outcome after ETS.
评估内镜经蝶窦手术(ETS)前后的视力(VA)和视野(VF),特别关注垂体腺瘤(PA)鞍上扩展(SSE)、体积以及患者年龄等预后因素。
对47例行ETS的PA患者的病历进行评估。测定VA、VF、术前视力损害评分(VISpre)和术后视力损害评分(VISpost)。术前和术后评估PA的SSE、体积、视交叉接触情况及其与视功能的相关性。
最终队列包括47例患者。ETS后76只眼中有54只眼(71.0%)的VA得到改善,76只眼中有69只眼(90.7%)的VA恢复正常。37只眼中有32只眼(86.5%)术后VF恢复。VIS的平均变化为12.0(95%置信区间[CI],7.7 - 16.3),所有与肿瘤相关视力损害的患者(n = 25)均有改善。然而,当VISpre大于40时,视力预后较差。当VISpre为21 - 40时,年龄与VIS改善呈线性相关(P = 0.03);年轻患者视力预后良好,老年患者较差。有VF缺陷的患者(n = 20)的平均SSE为16.6 mm(95% CI,13.3 - 19.9)。无VF缺陷的患者(n = 23)的平均SSE为6.6 mm(95% CI,4.9 - 8.3;P < 0.001),SSE导致视力障碍的临界值为9.5 mm,PA体积的临界值为8.6 mL(两者P均< 0.001)。
PA行ETS后的视力预后良好,严重并发症罕见。术前严重视力损害导致术后视力预后较差。PA的SSE是ETS后视力预后的最重要预测因素。